Preprint Body Surface Gastric Mapping Delineates Specific Patient Phenotypes In Adolescents With Functional Dyspepsia And Gastroparesis, 2024, Humphrey et al.

Discussion in 'Other health news and research' started by SNT Gatchaman, May 15, 2024 at 11:20 AM.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,599
    Location:
    Aotearoa New Zealand
    Body Surface Gastric Mapping Delineates Specific Patient Phenotypes In Adolescents With Functional Dyspepsia And Gastroparesis
    Gayl Humphrey; Celia Keane; Gabriel Schamberg; Alain Benitez; Stefan Calder; Binghong Xu; Christian Sadaka; Christopher N Andrews; Gregory O'Grady; Armen Gharibans; Hayat Mousa

    IMPORTANCE
    Persistent upper gastroduodenal symptoms, such as nausea, vomiting, bloating, and abdominal pain, are widespread among pediatric patients. Multiple overlapping symptoms complicate the diagnostic process, necessitating the development of novel gastric function tests with actionable biomarkers. Body Surface Gastric Mapping (BSGM) has emerged as a promising diagnostic tool for gastroduodenal disorders, and this is the first detailed evaluation in adolescents.

    OBJECTIVES
    This study aimed to assess the utility of BSGM in delineating specific patient phenotypes among adolescents with functional dyspepsia (FD) and gastroparesis in order to guide clinical decision-making.

    DESIGN
    A prospective cross-sectional study recruited adolescents aged 12 to 21 between 2022 and 2024.

    SETTING
    Controls were recruited from New Zealand (controls) and

    PATIENTS
    from the Children9s Hospital of Philadelphia, Pennsylvania, USA. Participants Prospectively recruited participants included controls without gastroduodenal symptoms or motility-related medication usage and patients diagnosed with either gastroparesis (delayed gastric emptying test (GET)) or FD according to ROME IV criteria and a normal GET. Procedures BSGM was performed using a standardized protocol, including simultaneous symptom reporting and the completion of validated symptom, psychometric and physical health questionnaires. Main Outcome The primary outcome was to evaluate if BSGM could delineate specific patient phenotypes and provide clinically meaningful distinctions between gastroparesis and FD diagnoses, utilizing BSGM spectral outcome data.

    RESULTS
    Fifty-six subjects were recruited (31 controls, 25 patients); median age 16; 96% of patients were female. Control data showed that adult reference intervals provided an acceptable interpretation framework. Patients with FD (n=10) and gastroparesis (n=15) had common symptoms, mental health, quality of life and functional disability (all p>0.05). Three distinct BSGM phenotypes were identified: BSGM Normal (n=10), BSGM Delay (n=8), and Low Stability/Low Amplitude (n=7), having spectral differences in BMI-Adjusted Amplitude 34.6 vs 39.1 vs 19.9 (p=.01) and Gastric Alimetry Rhythm Index: 0.45 vs 0.45 vs 0.19 (p=.003). BSGM phenotypes demonstrated differences in symptoms (nausea p=0.04), physical health (p=.04) and psychometrics (anxiety p=.03).

    CONCLUSIONS AND RELEVANCE
    Adolescent patients with FD and gastroparesis have overlapping clinical profiles, making individualized treatment challenging. Conversely, employing BSGM to categorize patients into distinct phenotypes revealed clinically relevant differences, offering potential avenues for individualized therapeutic pathways.


    Link | PDF (Preprint: MedRxiv) [Open Access]
     
    Deanne NZ, Peter Trewhitt and Sean like this.
  2. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,599
    Location:
    Aotearoa New Zealand

Share This Page